Brought to you by 
Qiagen acquires DNA amplification co. Molecular Staging
05 Oct 2004
Executive Summary
Nucleic acid products and services company Qiagen NV has acquired the assets of Molecular Staging Inc., a company with products and services relating to DNA amplification and the detection and measurement of proteins and nucleic acids. It paid $28.5mm in cash and could pay up to $6.75mm more in earnouts based on the achievement of specific sales goals.
Deal Industry
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Qiagen acquires DNA amplification co. Molecular Staging
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice